Verano Holdings (VRNO) Gross Margin (2021 - 2026)
Verano Holdings' (VRNO) quarterly Gross Margin came in at 47.54% in Q1 2026, up 8.0% year-on-year from 44.02% in Q1 2025, and down 7.06% on a QoQ basis from 51.16% in Q4 2025.
Verano Holdings (VRNO) Gross Margin (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Gross Margin data on file, last reported at 47.54% in Q1 2026.
- On a quarterly basis, Gross Margin rose 8.0% year-over-year to 47.54% in Q1 2026; TTM through Mar 2026 was 50.36%, a 71.0% increase from a year earlier, with the FY2025 full-year figure at 50.33%, down 19.0% from the prior year.
- Gross Margin for Q1 2026 stood at 47.54%, down from 51.16% in the prior quarter.
- Over the last five years, Gross Margin for VRNO reached as high as 13227.17% in Q1 2024 and fell as low as 43.87% in Q2 2022.
- Historically, Gross Margin has averaged 824.82% across 5 years, with a median of 49.28% in 2024.
- Across the five-year window, Gross Margin soared 1317908 bps in 2024 and tumbled 1317970 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 45.74% in 2022, then grew by 8 bps to 49.59% in 2023, then retreated by 1 bps to 49.28% in 2024, then climbed by 4 bps to 51.16% in 2025, then dropped by 7 bps to 47.54% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 47.54% in Q1 2026, 51.16% in Q4 2025, and 46.96% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 47.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.54% |
| Dec 31, 2025 | 51.16% |
| Sep 30, 2025 | 46.96% |
| Jun 30, 2025 | 55.86% |
| Mar 31, 2025 | 47.46% |
| Dec 31, 2024 | 49.28% |
| Sep 30, 2024 | 50.35% |
| Jun 30, 2024 | 51.41% |
| Mar 31, 2024 | 13,227.17% |
| Dec 31, 2023 | 49.59% |
| Sep 30, 2023 | 55.49% |
| Jun 30, 2023 | 49.20% |
| Mar 31, 2023 | 48.09% |
| Dec 31, 2022 | 45.74% |
| Sep 30, 2022 | 54.04% |
| Jun 30, 2022 | 43.87% |
| Mar 31, 2022 | 48.76% |
| Dec 31, 2021 | 51.71% |
| Sep 30, 2021 | 47.56% |
| Jun 30, 2021 | 34.77% |